PD-L1 expression on tumor cells as a potential predictive biomarker for patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab.

ABSTRACT:

SUBMITTER: Kasmann L 

PROVIDER: S-EPMC10175003 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature